Log In
BCIQ
Print this Print this
 

HCI-1401

  Manage Alerts
Collapse Summary General Information
Company LSK BioPharma Inc.
DescriptionSmall molecule that irreversibly inhibits Bruton's tyrosine kinase (Btk)
Molecular Target Bruton's tyrosine kinase (Btk)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat B cell malignancies
Regulatory Designation
PartnerUniversity of Utah

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/06/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today